Evidence map›Paper›PMID 24384694›Full record

ArticleThe Journal of investigative dermatology2014

EFdA, a reverse transcriptase inhibitor, potently blocks HIV-1 ex vivo infection of Langerhans cells within epithelium.

Takamitsu Matsuzawa, Tatsuyoshi Kawamura, Youichi Ogawa, Kenji Maeda, Hirotomo Nakata, Kohji Moriishi, Yoshio Koyanagi, Hiroyuki Gatanaga, Shinji Shimada, Hiroaki Mitsuya

Open access · bronzeAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of investigative dermatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. The role of human dendritic cells in HIV-1 infection.The Journal of investigative dermatology · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Takamitsu MatsuzawaFaculty of Medicine, Department of Dermatology, University of Yamanashi, Yamanashi, Japan.
Tatsuyoshi KawamuraFaculty of Medicine, Department of Dermatology, University of Yamanashi, Yamanashi, Japan. Electronic address: tkawa@yamanashi.ac.jp.
Youichi OgawaFaculty of Medicine, Department of Dermatology, University of Yamanashi, Yamanashi, Japan.
Kenji MaedaExperimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Hirotomo NakataDepartment of Infectious Diseases and Hematology, Kumamoto University School of Medicine, Kumamoto, Japan.
Kohji MoriishiFaculty of Medicine, Department of Microbiology, University of Yamanashi, Yamanashi, Japan.
Yoshio KoyanagiLaboratory of Viral Pathogenesis, Institute for Virus Research, Kyoto University, Kyoto, Japan.
Hiroyuki GatanagaAIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
Shinji ShimadaFaculty of Medicine, Department of Dermatology, University of Yamanashi, Yamanashi, Japan.
Hiroaki MitsuyaExperimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA; Department of Infectious Diseases and Hematology, Kumamoto University School of Medicine, Kumamoto, Japan.
University of Yamanashi · JPNational Institutes of Health · USKumamoto University · JPKyoto University · JPNational Center for Global Health and Medicine · JPUniversity of Yamanashi Hospital · JP

Funding

Development of Antiviral Therapy of HIV-1 InfectionZIASC006738 · NCI · DIVISION OF CLINICAL SCIENCES - NCI · PI MITSUYA, HIROAKI · 2009 to 2025
$10.0M
Intramural NIH HHS ZIA SC006738
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Administration, TopicalAnimalsAnti-HIV AgentsAnti-Infective AgentsCD4-Positive T-LymphocytesCoculture TechniquesDiazonium CompoundsDose-Response Relationship, DrugEpitheliumFarnesolHIV-1HIV InfectionsHumansLangerhans CellsMiceReverse Transcriptase InhibitorsAnti-HIV AgentsAnti-Infective AgentsDiazonium Compoundsepoxyfarnesyl diazoacetateFarnesolReverse Transcriptase Inhibitors

Identifiers

PMID24384694
PMCPMC8370670
OpenAlexW2066576884

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.